Functional changes in astrocytes by human T-lymphotropic virus type-1 T-lymphocytes

Area of Science:

• Neuroimmunology
• Virology
• Cellular Metabolism

Background:

• Human T-lymphotropic virus type-1 (HTLV-1) causes chronic progressive myelopathy (TSP/HAM), characterized by central nervous system (CNS) lesions and T-cell infiltration.
• Astrocytes, critical glial cells, play a vital role in maintaining CNS homeostasis, including neurotransmitter regulation.

Purpose of the Study:

• To investigate the metabolic impact of HTLV-1-infected T-cells on astrocytes in a model mimicking CNS interactions.
• To elucidate the role of HTLV-1 and its protein Tax-1 in altering astrocyte glutamate metabolism and transporter expression.

Main Methods:

• Utilized a co-culture model simulating glial-T-cell interactions.
• Assessed astrocyte metabolic activity, including glucose and glutamate uptake, and lactate release.
• Quantified the expression of glutamate transporters (GLAST, GLT-1) and metabolic enzymes (GS, GDH).

Main Results:

• Transient contact with HTLV-1-infected T-cells induced biphasic alterations in astrocyte metabolism.
• Early-stage activation showed increased glucose/glutamate uptake and lactate release.
• Later stages revealed reduced glutamate accumulation, decreased GLAST/GLT-1 expression, and imbalanced GS/GDH expression, linked to Tax-1 and TNF-alpha.

Conclusions:

• HTLV-1 infection profoundly alters astrocyte metabolism and glutamate handling.
• Impaired glutamate management by astrocytes, driven by HTLV-1 Tax-1, may compromise neuronal and oligodendrocyte integrity.
• These findings provide novel insights into the physiopathology of TSP/HAM and CNS dysfunction.